Biocompatible dextran-coated gadolinium-doped cerium oxide nanoparticles as MRI contrast agents with high T 1 relaxivity and selective cytotoxicity to cancer cells
- 3 August 2021
- journal article
- retracted article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (33) , 6586-6599
Abstract
Dextran-coated gadolinium-modified ceria nanoparticles possess excellent colloidal stability, high r 1 -relaxivity, demonstrate efficient cell internalisation and selective cytotoxicity to cancer cells.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (075-15-2020-779)
This publication has 90 references indexed in Scilit:
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian CancerPLOS ONE, 2013
- Synthesis and antioxidant activity of biocompatible maltodextrin-stabilized aqueous sols of nanocrystalline ceriaRussian Journal of Inorganic Chemistry, 2012
- Microwave-hydrothermal synthesis of gadolinium-doped nanocrystalline ceria in the presence of hexamethylenetetramineRussian Journal of Inorganic Chemistry, 2012
- Antioxidative and Radiation Modulating Properties of Guanosine-5′-MonophosphateNucleosides, Nucleotides & Nucleic Acids, 2010
- Surface-Charge-Dependent Cell Localization and Cytotoxicity of Cerium Oxide NanoparticlesACS Nano, 2010
- Method for Analysis of Nanoparticle Hemolytic Properties in VitroNano Letters, 2008
- The role of cerium redox state in the SOD mimetic activity of nanoceriaBiomaterials, 2008
- Toxicity of Cerium Oxide Nanoparticles in Human Lung Cancer CellsInternational Journal of Toxicology, 2006
- Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian CellsNano Letters, 2006
- ELECTRON ENERGY LOSS SPECTROMETRY2005